EUVIMEDEUVIMED entdecken
Crossref

Tofacitinib Rescue for Refractory Drug‐Induced Liver Injury With Severe DRESS : A Prospective Proof‐of‐Concept Study

Jingyan Gu, Yuan Wang, Xiaoyu Wang, Yingying Yan, Fei Pei, Tianyu He, Chunlei Zhang, Jun Li, Wenhui Wang iD

Liver International · 2026

DOI: 10.1111/liv.70578 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Jingyan Gu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Piperidines, Pyrimidines, Chemical and Drug Induced Liver Injury, Drug Hypersensitivity Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug‐induced liver injury (DILI) with severe DRESS carries high mortality, yet rescue therapies for corticosteroid‐refractory cases remain undefined. We hypothesized that JAK inhibition could reverse refractory liver injury by targeting the underlying cytokine storm. In this prospective proof‐of‐concept study, consecutive patients with severe DRESS‐associated DILI refractory to corticosteroids (persistent/worsening liver injury) received oral tofacitinib rescue. Key assessments were the normalisation of liver biochemistries. Despite initial corticosteroids, all four patients exhibited progressive severe injury (median peak ALT 1126 U/L). Tofacitinib rapidly reversed liver injury in all cases. Transaminases normalised or near‐normalised (median: 48 days), total bilirubin normalised, and cutaneous symptoms resolved completely. Notably, baseline positive autoantibodies seroconverted to negative. No severe adverse events occurred (median follow‐up: 274 days). Tofacitinib shows promise as a rescue strategy for corticosteroid‐refractory DILI with severe DRESS. The rapid recovery underscores the JAK–STAT pathway's pathogenic role in this setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PiperidinesPyrimidinesChemical and Drug Induced Liver InjuryDrug Hypersensitivity SyndromeJanus Kinase InhibitorsPyrrolesProtein Kinase InhibitorsHumansMaleProspective StudiesProof of Concept StudyFemaleMiddle AgedAgedTreatment OutcomeAdrenal Cortex Hormones

Stichwörter der Autor:innen

JAK inhibitordrug reaction with eosinophilia and systemic symptomsdrug‐induced liver injuryimmunomodulationliver functiontofacitinib

Substanzen

tofacitinibPiperidinesPyrimidinesJanus Kinase InhibitorsPyrrolesAdrenal Cortex HormonesProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Dermatology, Peking University Third Hospital, Beijing, China.
  • Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Department of Pathology, Peking University Third Hospital, Beijing, China.
  • Department of Gastroenterology, Peking University Third Hospital, Beijing, China.

ORCID-Profile: Wenhui Wang

Zitieren

APA

Gu, J., Wang, Y., Wang, X., Yan, Y., Pei, F., He, T., Zhang, C., Li, J., & Wang, W. (2026). Tofacitinib Rescue for Refractory Drug‐Induced Liver Injury With Severe DRESS : A Prospective Proof‐of‐Concept Study. Liver International. https://doi.org/10.1111/liv.70578

Vancouver

Gu J, Wang Y, Wang X, Yan Y, Pei F, He T, et al. Tofacitinib Rescue for Refractory Drug‐Induced Liver Injury With Severe DRESS : A Prospective Proof‐of‐Concept Study. Liver International. 2026. doi:10.1111/liv.70578

BibTeX
@article{Gu2026,
  author = {Gu, Jingyan and Wang, Yuan and Wang, Xiaoyu and Yan, Yingying and Pei, Fei and He, Tianyu and Zhang, Chunlei and Li, Jun and Wang, Wenhui},
  title = {Tofacitinib Rescue for Refractory Drug‐Induced Liver Injury With Severe DRESS : A Prospective Proof‐of‐Concept Study},
  journal = {Liver International},
  year = {2026},
  doi = {10.1111/liv.70578}
}
Kostenlos starten →